![](/img/cover-not-exists.png)
Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01
Anders Fomsgaard, Ingrid Karlsson, Gregers Gram, Christian Schou, Sheila Tang, Peter Bang, Ingrid Kromann, Peter Andersen, Lars Vibe AndreasenVolume:
29
Year:
2011
Language:
english
DOI:
10.1016/j.vaccine.2011.07.025
File:
PDF, 337 KB
english, 2011